Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: March 3, 2026, 1:36 pm
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 524212 | NSE: WANBURY

Wanbury Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: March 3, 2026, 1:36 pm

Market Cap 885 Cr.
Current Price 253
Intrinsic Value₹204.63
High / Low 330/156
Stock P/E20.6
Book Value 18.1
Dividend Yield0.00 %
ROCE36.7 %
ROE76.5 %
Face Value 10.0
PEG Ratio-1.70

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Wanbury Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Wanbury Ltd 885 Cr. 253 330/15620.6 18.10.00 %36.7 %76.5 % 10.0
Venus Remedies Ltd 871 Cr. 651 873/27811.4 4450.00 %11.1 %7.16 % 10.0
Fredun Pharmaceuticals Ltd 837 Cr. 1,560 1,999/63524.6 2940.04 %18.9 %15.8 % 10.0
Fermenta Biotech Ltd 939 Cr. 319 399/22510.6 1330.78 %23.0 %24.9 % 5.00
Anuh Pharma Ltd 775 Cr. 77.3 115/68.018.5 32.61.94 %17.2 %13.4 % 5.00
Industry Average20,512.19 Cr1,093.4253.22201.810.38%16.35%15.16%6.10

All Competitor Stocks of Wanbury Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 117124126133146144146139131161133172163
Expenses 120118119119133127124121120141120142139
Operating Profit -36614131721181120143024
OPM % -3%5%5%11%9%12%15%13%8%12%10%17%15%
Other Income 210-31112612120
Interest 347868878101098
Depreciation 3333333333334
Profit before tax -7-1-315710341811914
Tax % -3%25%8%-11%6%-2%-0%1%0%2%5%-6%1%
Net Profit -7-1-315710341812013
EPS in Rs -2.21-0.27-1.000.311.432.253.1410.270.322.450.376.184.10

Last Updated: August 20, 2025, 1:15 am

Below is a detailed analysis of the quarterly data for Wanbury Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 163.00 Cr.. The value appears to be declining and may need further review. It has decreased from 172.00 Cr. (Mar 2025) to 163.00 Cr., marking a decrease of 9.00 Cr..
  • For Expenses, as of Jun 2025, the value is 139.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 142.00 Cr. (Mar 2025) to 139.00 Cr., marking a decrease of 3.00 Cr..
  • For Operating Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 6.00 Cr..
  • For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Mar 2025) to 15.00%, marking a decrease of 2.00%.
  • For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 2.00 Cr..
  • For Interest, as of Jun 2025, the value is 8.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 1.00 Cr..
  • For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
  • For Profit before tax, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 5.00 Cr..
  • For Tax %, as of Jun 2025, the value is 1.00%. The value appears to be increasing, which may not be favorable. It has increased from -6.00% (Mar 2025) to 1.00%, marking an increase of 7.00%.
  • For Net Profit, as of Jun 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 7.00 Cr..
  • For EPS in Rs, as of Jun 2025, the value is 4.10. The value appears to be declining and may need further review. It has decreased from 6.18 (Mar 2025) to 4.10, marking a decrease of 2.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:08 am

MetricSep 2014n n 18mMar 2015n n 6mMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 661250420432370391367392511485578600630
Expenses 637228387414438375344374475459503520542
Operating Profit 25213319-681623183626758088
OPM % 4%9%8%4%-18%4%6%5%7%5%13%13%14%
Other Income -78609076984277-324-05
Interest 48193236314033232121293737
Depreciation 235910101010101112131314
Profit before tax -1254-762-32-2565-1281-10563042
Tax % 2%28%0%1%-1%-1%0%2%-0%1%1%-3%
Net Profit -1283-762-32-2564-1381-10563143
EPS in Rs -63.951.60-3.5826.71-13.49-10.4825.79-5.0424.94-3.1817.099.3213.10
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)985.71%-151.61%21.88%356.00%-120.31%723.08%-112.35%660.00%-44.64%
Change in YoY Net Profit Growth (%)0.00%-1137.33%173.49%334.12%-476.31%843.39%-835.42%772.35%-704.64%

Wanbury Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:10%
3 Years:5%
TTM:12%
Compounded Profit Growth
10 Years:25%
5 Years:30%
3 Years:75%
TTM:60%
Stock Price CAGR
10 Years:16%
5 Years:49%
3 Years:61%
1 Year:15%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:70%

Last Updated: September 5, 2025, 1:55 pm

Balance Sheet

Last Updated: October 10, 2025, 3:15 pm

MonthSep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 202020232424252533333333
Reserves -212-214-209-176-208-233-168-181-56-66-526
Borrowings 38938136230025026019019210095116179
Other Liabilities 209209215265207236232253276241199176
Total Liabilities 406396388412273286279289353304343414
Fixed Assets 174164180186178172164167167167167201
CWIP 1319141010914112235
Investments 000000000000
Other Assets 21921319321684105101111183135173208
Total Assets 406396388412273286279289353304343414

Below is a detailed analysis of the balance sheet data for Wanbury Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 33.00 Cr..
  • For Reserves, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from -5.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 31.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 179.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 116.00 Cr. (Mar 2024) to 179.00 Cr., marking an increase of 63.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 176.00 Cr.. The value appears to be improving (decreasing). It has decreased from 199.00 Cr. (Mar 2024) to 176.00 Cr., marking a decrease of 23.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 414.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 343.00 Cr. (Mar 2024) to 414.00 Cr., marking an increase of 71.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 167.00 Cr. (Mar 2024) to 201.00 Cr., marking an increase of 34.00 Cr..
  • For CWIP, as of Mar 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 5.00 Cr., marking an increase of 2.00 Cr..
  • For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 208.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 208.00 Cr., marking an increase of 35.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 414.00 Cr.. The value appears strong and on an upward trend. It has increased from 343.00 Cr. (Mar 2024) to 414.00 Cr., marking an increase of 71.00 Cr..

However, the Borrowings (179.00 Cr.) are higher than the Reserves (26.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthSep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 68404343323044174120526
Cash from Investing Activity + -6-5-20-13-1-36481-9-17-51
Cash from Financing Activity + -71-30-28-27-33-27-108-17-29-321426
Net Cash Flow -95-53-2-0-0713-2121

Free Cash Flow

MonthMar 2015n n 6mMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2014n n 18m
Free Cash Flow21.00-329.00-281.00-318.00-244.00-167.00-174.00-64.00-69.00-41.00-99.0025.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthSep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 5714465712941503245525670
Inventory Days 4210369632736254160264347
Days Payable 113301172260174209253221218179196172
Cash Conversion Cycle -14-55-38-125-118-131-177-148-113-101-96-55
Working Capital Days -44-140-123-185-277-254-236-251-153-152-374
ROCE %4%12%57%-1%26%31%27%46%21%61%37%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 39.84%39.84%39.80%39.79%39.79%39.79%39.77%39.76%39.76%39.63%43.09%43.08%
FIIs 0.00%0.00%0.00%0.00%0.18%0.22%1.02%0.84%1.55%1.59%0.82%0.72%
Public 60.16%60.16%60.19%60.20%60.02%59.97%59.21%59.40%58.68%58.79%56.08%56.21%
No. of Shareholders 11,91111,74111,63411,61613,08714,40017,19917,99917,88917,89417,71717,261

Shareholding Pattern Chart

No. of Shareholders

Wanbury Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 9.3217.10-3.1825.29-5.04
Diluted EPS (Rs.) 8.9816.89-3.1825.21-5.04
Cash EPS (Rs.) 13.3821.070.6028.45-1.14
Book Value[Excl.RevalReserv]/Share (Rs.) 18.098.53-10.03-7.17-62.46
Book Value[Incl.RevalReserv]/Share (Rs.) 18.098.53-10.03-7.17-62.46
Revenue From Operations / Share (Rs.) 182.94175.79152.77156.49156.91
PBDIT / Share (Rs.) 24.3522.297.3611.278.16
PBIT / Share (Rs.) 20.2918.313.587.774.26
PBT / Share (Rs.) 9.0217.20-3.1524.84-4.96
Net Profit / Share (Rs.) 9.3217.09-3.1824.94-5.04
NP After MI And SOA / Share (Rs.) 9.3217.09-3.1824.94-5.04
PBDIT Margin (%) 13.3112.674.827.205.20
PBIT Margin (%) 11.0910.412.344.962.71
PBT Margin (%) 4.929.78-2.0515.87-3.16
Net Profit Margin (%) 5.099.72-2.0815.93-3.21
NP After MI And SOA Margin (%) 5.099.72-2.0815.93-3.21
Return on Networth / Equity (%) 51.50200.260.00-347.880.00
Return on Capital Employeed (%) 27.7846.34-70.89-351.22-16.12
Return On Assets (%) 7.3716.29-3.4223.10-4.35
Long Term Debt / Equity (X) 2.702.930.000.00-0.46
Total Debt / Equity (X) 2.923.94-1.95-2.86-0.56
Asset Turnover Ratio (%) 1.581.781.521.601.39
Current Ratio (X) 1.110.740.380.480.28
Quick Ratio (X) 0.890.570.310.340.21
Inventory Turnover Ratio (X) 16.279.977.188.1811.52
Interest Coverage Ratio (X) 2.162.501.131.790.88
Interest Coverage Ratio (Post Tax) (X) 1.832.040.541.250.45
Enterprise Value (Cr.) 929.36581.65182.26319.37284.21
EV / Net Operating Revenue (X) 1.551.010.360.620.72
EV / EBITDA (X) 11.647.977.578.6713.92
MarketCap / Net Operating Revenue (X) 1.280.820.240.540.52
Price / BV (X) 12.9717.09-3.72-11.86-1.33
Price / Net Operating Revenue (X) 1.280.820.240.540.52
EarningsYield 0.030.11-0.080.29-0.06

After reviewing the key financial ratios for Wanbury Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 9.32. This value is within the healthy range. It has decreased from 17.10 (Mar 24) to 9.32, marking a decrease of 7.78.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 8.98. This value is within the healthy range. It has decreased from 16.89 (Mar 24) to 8.98, marking a decrease of 7.91.
  • For Cash EPS (Rs.), as of Mar 25, the value is 13.38. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.38, marking a decrease of 7.69.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 18.09. It has increased from 8.53 (Mar 24) to 18.09, marking an increase of 9.56.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 18.09. It has increased from 8.53 (Mar 24) to 18.09, marking an increase of 9.56.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 182.94. It has increased from 175.79 (Mar 24) to 182.94, marking an increase of 7.15.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 24.35. This value is within the healthy range. It has increased from 22.29 (Mar 24) to 24.35, marking an increase of 2.06.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 20.29. This value is within the healthy range. It has increased from 18.31 (Mar 24) to 20.29, marking an increase of 1.98.
  • For PBT / Share (Rs.), as of Mar 25, the value is 9.02. This value is within the healthy range. It has decreased from 17.20 (Mar 24) to 9.02, marking a decrease of 8.18.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 9.32. This value is within the healthy range. It has decreased from 17.09 (Mar 24) to 9.32, marking a decrease of 7.77.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.32. This value is within the healthy range. It has decreased from 17.09 (Mar 24) to 9.32, marking a decrease of 7.77.
  • For PBDIT Margin (%), as of Mar 25, the value is 13.31. This value is within the healthy range. It has increased from 12.67 (Mar 24) to 13.31, marking an increase of 0.64.
  • For PBIT Margin (%), as of Mar 25, the value is 11.09. This value is within the healthy range. It has increased from 10.41 (Mar 24) to 11.09, marking an increase of 0.68.
  • For PBT Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 10. It has decreased from 9.78 (Mar 24) to 4.92, marking a decrease of 4.86.
  • For Net Profit Margin (%), as of Mar 25, the value is 5.09. This value is within the healthy range. It has decreased from 9.72 (Mar 24) to 5.09, marking a decrease of 4.63.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.09. This value is below the healthy minimum of 8. It has decreased from 9.72 (Mar 24) to 5.09, marking a decrease of 4.63.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 51.50. This value is within the healthy range. It has decreased from 200.26 (Mar 24) to 51.50, marking a decrease of 148.76.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 27.78. This value is within the healthy range. It has decreased from 46.34 (Mar 24) to 27.78, marking a decrease of 18.56.
  • For Return On Assets (%), as of Mar 25, the value is 7.37. This value is within the healthy range. It has decreased from 16.29 (Mar 24) to 7.37, marking a decrease of 8.92.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 2.70. This value exceeds the healthy maximum of 1. It has decreased from 2.93 (Mar 24) to 2.70, marking a decrease of 0.23.
  • For Total Debt / Equity (X), as of Mar 25, the value is 2.92. This value exceeds the healthy maximum of 1. It has decreased from 3.94 (Mar 24) to 2.92, marking a decrease of 1.02.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.58. It has decreased from 1.78 (Mar 24) to 1.58, marking a decrease of 0.20.
  • For Current Ratio (X), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 1.5. It has increased from 0.74 (Mar 24) to 1.11, marking an increase of 0.37.
  • For Quick Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.89, marking an increase of 0.32.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 16.27. This value exceeds the healthy maximum of 8. It has increased from 9.97 (Mar 24) to 16.27, marking an increase of 6.30.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 2.16. This value is below the healthy minimum of 3. It has decreased from 2.50 (Mar 24) to 2.16, marking a decrease of 0.34.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 3. It has decreased from 2.04 (Mar 24) to 1.83, marking a decrease of 0.21.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 929.36. It has increased from 581.65 (Mar 24) to 929.36, marking an increase of 347.71.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has increased from 1.01 (Mar 24) to 1.55, marking an increase of 0.54.
  • For EV / EBITDA (X), as of Mar 25, the value is 11.64. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 11.64, marking an increase of 3.67.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 1.28, marking an increase of 0.46.
  • For Price / BV (X), as of Mar 25, the value is 12.97. This value exceeds the healthy maximum of 3. It has decreased from 17.09 (Mar 24) to 12.97, marking a decrease of 4.12.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 1.28, marking an increase of 0.46.
  • For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.03, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Wanbury Ltd as of March 5, 2026 is: ₹232.75

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 5, 2026, Wanbury Ltd is Overvalued by 8.00% compared to the current share price ₹253.00

Intrinsic Value of Wanbury Ltd as of March 5, 2026 is: ₹204.63

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 5, 2026, Wanbury Ltd is Overvalued by 19.12% compared to the current share price ₹253.00

Last 5 Year EPS CAGR: -12.08%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 26.75%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -154.00, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -97.58, which is a positive sign.
  4. The company has shown consistent growth in sales (468.23 cr) and profit (9.92 cr) over the years.
  1. The company has higher borrowings (234.50) compared to reserves (-141.83), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Wanbury Ltd:
    1. Net Profit Margin: 5.09%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 27.78% (Industry Average ROCE: 16.35%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 51.5% (Industry Average ROE: 15.16%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 1.83
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.89
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 20.6 (Industry average Stock P/E: 53.22)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 2.92
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 599.51 Cr. and Equity Capital is Rs. 32.77 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsBSEL Tech Park, B-Wing, 10th Floor, Sector 30-A, New Mumbai Maharashtra 400703Contact not found
Management
NamePosition Held
Mr. K ChandranWhole Time Director
Mr. Mohan Kumar RayanaWhole Time Director
Ms. Anupama VaidyaInd. Non-Executive Woman Director
Mr. Mridul Sumanlal MehtaInd. Non-Executive Director
Mr. P V Sankar DassInd. Non-Executive Director
Mr. Manojkumar K GursahaniInd. Non-Executive Director

FAQ

What is the intrinsic value of Wanbury Ltd?

Wanbury Ltd's intrinsic value (as of 05 March 2026) is ₹204.63 which is 19.12% lower the current market price of ₹253.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹885 Cr. market cap, FY2025-2026 high/low of ₹330/156, reserves of ₹26 Cr, and liabilities of ₹414 Cr.

What is the Market Cap of Wanbury Ltd?

The Market Cap of Wanbury Ltd is 885 Cr..

What is the current Stock Price of Wanbury Ltd as on 05 March 2026?

The current stock price of Wanbury Ltd as on 05 March 2026 is ₹253.

What is the High / Low of Wanbury Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Wanbury Ltd stocks is ₹330/156.

What is the Stock P/E of Wanbury Ltd?

The Stock P/E of Wanbury Ltd is 20.6.

What is the Book Value of Wanbury Ltd?

The Book Value of Wanbury Ltd is 18.1.

What is the Dividend Yield of Wanbury Ltd?

The Dividend Yield of Wanbury Ltd is 0.00 %.

What is the ROCE of Wanbury Ltd?

The ROCE of Wanbury Ltd is 36.7 %.

What is the ROE of Wanbury Ltd?

The ROE of Wanbury Ltd is 76.5 %.

What is the Face Value of Wanbury Ltd?

The Face Value of Wanbury Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Wanbury Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports